高强度聚焦超声消融治疗子宫肌瘤的评估:IDEAL前瞻性探索性研究
这项在中国20家医院开展的前瞻性多中心患者选择队列研究(IDEAL探索性研究)纳入2411例子宫肌瘤患者,比较高强度聚焦超声(HIFU)、子宫肌瘤剔除术或子宫切除术的临床结局。HIFU组严重不良事件发生率为0.2%,手术组为12.6%;HIFU组术后6个月UFS和QoL改善更快但绝对差异小,长期QoL相似。作者认为这些发现支持开展HIFU治疗子宫肌瘤的随机对照试验。
要点
- HIFU组严重不良事件3例(0.2%),手术组133例(12.6%)(P < 0.001)。
- HIFU组住院中位时间4天,子宫切除术组10天,子宫肌瘤剔除术组8天。
- HIFU组6个月时UFS和QoL改善快于手术组,但绝对差异小,长期QoL相似。
核心结论
- HIFU导致的发病率明显低于手术,长期生活质量相似。
- 尽管存在组间基线差异且缺乏盲法,这些发现支持开展HIFU治疗子宫肌瘤的随机对照试验。
- IDEAL探索性设计促进了随机对照试验方案的制定。
研究设计与样本
- 前瞻性多中心患者选择队列研究(IDEAL探索性研究),比较HIFU、子宫肌瘤剔除术或子宫切除术治疗症状性子宫肌瘤。
- 研究在20家中国医院开展,纳入2411例症状性子宫肌瘤中国女性。
- 采用学习曲线分析(IDEAL 2b期前瞻性探索性研究),用LC-CUSUM评估HIFU治疗质量以识别操作者学习曲线。
- 主要结局指标为并发症、住院时间、恢复正常活动、生活质量(基线、6个月和12个月用UFS-QoL和SF-36测量)及是否需要进一步治疗。
- 生活质量结局采用回归模型校正,并进行了成本卫生经济学分析。
主要发现
- 1353例女性接受HIFU,472例接受子宫切除术,586例接受子宫肌瘤剔除术。
- HIFU组患者较手术组显著更年轻(P < 0.001)、更瘦(P < 0.001)、受教育程度更高(P < 0.001)、更富裕(P = 0.002)。
- HIFU组6个月时UFS和QoL改善快于手术组(P = 0.002和P = 0.001),但绝对差异小。
- HIFU组严重不良事件3例(0.2%),手术组133例(12.6%)(P < 0.001)。
- 住院中位时间:HIFU组4天(四分位距0-5天),子宫切除术组10天(四分位距8-12.5天),子宫肌瘤剔除术组8天(四分位距7-10天)。
临床怎么用
- 作者认为这些发现支持开展HIFU治疗子宫肌瘤的随机对照试验。
- IDEAL探索性设计促进了随机对照试验方案的制定。
局限性
- 存在组间基线差异。
- 缺乏盲法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the clinical outcomes of high-intensity focused ultrasound (HIFU) and surgery in treating uterine fibroids, and prepare for a definitive randomised trial. DESIGN: Prospective multicentre patient choice cohort study (IDEAL Exploratory study) of HIFU, myomectomy or hysterectomy for treating symptomatic uterine fibroids. SETTING: 20 Chinese hospitals. POPULATION OR SAMPLE: 2411 Chinese women with symptomatic fibroids. METHODS: Prospective non-randomised cohort study with learning curve analysis (IDEAL Stage 2b Prospective Exploration Study). MAIN OUTCOME MEASURES: Complications, hospital stay, return to normal activities, and quality of life (measured with UFS-Qol and SF-36 at baseline, 6 and 12 months), and need for further treatment. Quality-of-life outcomes were adjusted using regression modelling. HIFU treatment quality was evaluated using LC-CUSUM to identify operator learning curves. A health economic analysis of costs was performed. RESULTS: 1353 women received HIFU, 472 hysterectomy and 586 myomectomy. HIFU patients were significantly younger (P < 0.001), slimmer (P < 0.001), better educated (P < 0.001), and wealthier (P = 0.002) than surgery patients. Both UFS and QoL improved more rapidly after HIFU than after surgery (P = 0.002 and P = 0.001, respectively at 6 months), but absolute differences were small. Major adverse events occurred in 3 (0.2%) of HIFU and in 133 (12.6%) of surgical cases (P < 0.001). Median time for hospital stay was 4 days (interquartile range, 0-5 days), 10 days (interquartile range, 8-12.5 days) and 8 days (interquartile range, 7-10 days). CONCLUSIONS: HIFU caused substantially less morbidity than surgery, with similar longer-term QoL. Despite group baseline differences and lack of blinding, these findings support the need for a randomised controlled trial (RCT) of HIFU treatment for fibroids. The IDEAL Exploratory design facilitated RCT protocol development. TWEETABLE ABSTRACT: HIFU had much better short-term outcomes than surgery for fibroids in 2411-patient Chinese IDEAL format study.
引用
- Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2017. PMID: 28421665. doi:10.1111/1471-0528.14689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。